HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroya Kobayashi Selected Research

HLA-DR9 antigen

5/2005Recognition of prostate and breast tumor cells by helper T lymphocytes specific for a prostate and breast tumor-associated antigen, TARP.
10/2004Recognition of adult T-cell leukemia/lymphoma cells by CD4+ helper T lymphocytes specific for human T-cell leukemia virus type I envelope protein.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroya Kobayashi Research Topics

Disease

40Neoplasms (Cancer)
08/2022 - 03/2002
8Squamous Cell Carcinoma of Head and Neck
01/2022 - 09/2014
8Lymphoma (Lymphomas)
01/2019 - 10/2004
6T-Cell Lymphoma (Lymphoma, T Cell)
02/2015 - 10/2004
5Breast Neoplasms (Breast Cancer)
11/2021 - 05/2005
5Bites and Stings (Sting)
11/2021 - 06/2017
5Melanoma (Melanoma, Malignant)
06/2017 - 06/2007
4Leukemia
07/2021 - 12/2005
3Colonic Neoplasms (Colon Cancer)
08/2022 - 03/2016
3Inflammation (Inflammations)
11/2018 - 04/2003
3Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 04/2008
3Carcinoma (Carcinomatosis)
11/2015 - 10/2002
3T-Cell Leukemia (Leukemia, T Cell)
12/2012 - 10/2004
3Infections
03/2009 - 10/2006
3Prostatic Neoplasms (Prostate Cancer)
06/2007 - 11/2003
2Neoplasm Metastasis (Metastasis)
08/2022 - 06/2009
2Colorectal Neoplasms (Colorectal Cancer)
08/2022 - 06/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020 - 06/2017
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2012 - 10/2004
2Urinary Bladder Neoplasms (Bladder Cancer)
07/2010 - 05/2010
1Hypoxia (Hypoxemia)
08/2022
1Carcinogenesis
08/2022
1Pain (Aches)
08/2022
1Hereditary Folate Malabsorption
06/2022
1Megaloblastic Anemia
06/2022
1Hemorrhage
06/2022
1Thrombocytopenia (Thrombopenia)
06/2022
1Multiple Organ Failure (MODS)
06/2022
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2021
1Hypotension (Low Blood Pressure)
09/2021
1Hypertension (High Blood Pressure)
09/2021
1Collagenous Colitis
09/2021
1Atrophy
09/2021
1Triple Negative Breast Neoplasms
05/2021
1Testicular Neoplasms (Testicular Cancer)
12/2020
1Bone Resorption
06/2020
1Periodontal Diseases (Periodontal Disease)
06/2020

Drug/Important Bio-Agent (IBA)

25AntigensIBA
08/2022 - 03/2002
25Peptides (Polypeptides)IBA
12/2021 - 10/2002
20EpitopesIBA
12/2021 - 10/2002
12Proteins (Proteins, Gene)FDA Link
07/2021 - 10/2002
10VaccinesIBA
12/2021 - 03/2002
7T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2021 - 10/2004
6LigandsIBA
11/2021 - 02/2015
5HLA-DR Antigens (HLA-DR)IBA
12/2021 - 09/2014
5cyclic guanosine monophosphate-adenosine monophosphateIBA
11/2021 - 06/2017
4Membrane Proteins (Integral Membrane Proteins)IBA
05/2010 - 10/2006
4Messenger RNA (mRNA)IBA
03/2009 - 04/2004
3InterferonsIBA
08/2022 - 01/2018
3Protein Subunit VaccinesIBA
01/2022 - 10/2006
3Neoplasm Antigens (Tumor Antigens)IBA
12/2021 - 10/2002
3Monoclonal AntibodiesIBA
08/2021 - 04/2003
3Interferon Type IIBA
08/2021 - 06/2017
3ChemokinesIBA
06/2017 - 06/2015
3HLA-DR15 antigenIBA
12/2012 - 10/2004
2Cancer VaccinesIBA
08/2022 - 12/2021
2Tyrosine Kinase InhibitorsIBA
01/2022 - 11/2015
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2017
2Pharmaceutical PreparationsIBA
09/2021 - 01/2020
2DNA (Deoxyribonucleic Acid)IBA
05/2021 - 06/2016
2HLA Antigens (Human Leukocyte Antigens)IBA
12/2020 - 06/2007
2CytokinesIBA
01/2019 - 09/2014
2B7-H1 AntigenIBA
01/2019 - 07/2017
2Histocompatibility Antigens Class IIIBA
05/2014 - 07/2006
2HLA-DR53IBA
12/2012 - 05/2005
2Complementary DNA (cDNA)IBA
12/2007 - 12/2005
2AutoantigensIBA
06/2006 - 10/2004
2HLA-DR9 antigenIBA
05/2005 - 10/2004
2Carcinoembryonic AntigenIBA
04/2004 - 10/2002
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2022
1Mitogen-Activated Protein Kinase 3IBA
08/2022
1Double-Stranded RNA (RNA, Double Stranded)IBA
08/2022
1Poly I-CIBA
08/2022
1Neurokinin-2 Receptors (Neurokinin 2 Receptor)IBA
08/2022
1Neurokinin AIBA
08/2022
1TachykininsIBA
08/2022
1Folic Acid (Vitamin M)FDA LinkGeneric
06/2022
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2022
1Mitogen-Activated Protein KinasesIBA
01/2022
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2021
1Combined VaccinesIBA
12/2021
1nutlin 3IBA
12/2021
1MHC class II transactivator proteinIBA
12/2021
1Granzymes (Granzyme)IBA
12/2021
1olmesartanIBA
09/2021
1Angiotensin Receptor AntagonistsIBA
09/2021
1CollagenIBA
09/2021
1Adenosine Monophosphate (AMP)IBA
08/2021
1Guanosine Monophosphate (5' Guanylic Acid)IBA
08/2021
1Circulating Tumor DNAIBA
05/2021
1terreinIBA
06/2020
1VimentinIBA
06/2020
1Cisplatin (Platino)FDA LinkGeneric
01/2020
1PlicamycinFDA Link
01/2019
1SurvivinIBA
01/2019

Therapy/Procedure

31Immunotherapy
08/2022 - 10/2002
13Therapeutics
11/2021 - 04/2004
2Drug Therapy (Chemotherapy)
01/2018 - 10/2004
1Immunomodulation
01/2022
1Transplantation
08/2021